Literature DB >> 3940677

The association of dyslipoproteinemia with corneal arcus and xanthelasma. The Lipid Research Clinics Program Prevalence Study.

P Segal, W Insull, L E Chambless, S Stinnett, J C LaRosa, L Weissfeld, S Halfon, P O Kwiterovitch, J A Little.   

Abstract

The prevalence rates of xanthelasma and corneal arcus were computed for normolipidemic and dyslipoproteinemic participants in the Lipid Research Clinics population surveys. The prevalence of both xanthelasma and corneal arcus increased with age, was highest in persons with type II phenotype, and usually low in those with type IV phenotype. The relative effects of age and use of gonadal hormones were different in the two lesions. Both xanthelasma and corneal arcus were associated with increased levels of plasma cholesterol and low-density lipoprotein cholesterol (LDL-C), especially in young males. In general, persons with either lesion had increased odds of having type IIa dyslipoproteinemia but decreased odds of having type IV. Xanthelasma and corneal arcus were highly associated with each other, especially in young people. There was no consistent univariate association of xanthelasma and corneal arcus with smoking, alcohol consumption, blood pressure, obesity, sedentary lifestyle, family history of ischemic heart disease, or glucose and uric acid plasma concentrations. Adjusted odds ratios for ischemic heart disease in participants with xanthelasma and corneal arcus were generally increased, except in older female nonusers of gonadal hormones, in whom they were significantly decreased. Neither xanthelasma nor corneal arcus showed a consistent association with manifestations of peripheral arterial disease. Thus the clinical findings of xanthelasma or corneal arcus, especially in young people, seem to identify persons with plasma lipoprotein abnormalities.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3940677

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

1.  Xanthelasma Palpebrarum-clinical and biochemical profile in a tertiary care hospital of Delhi.

Authors:  A Jain; P Goyal; P K Nigam; H Gurbaksh; R C Sharma
Journal:  Indian J Clin Biochem       Date:  2007-09

2.  Disappearance of eyelid xanthelasma following oral simvastatin (Zocor).

Authors:  C L Shields; A Mashayekhi; J A Shields; P Racciato
Journal:  Br J Ophthalmol       Date:  2005-05       Impact factor: 4.638

Review 3.  [Cutaneous manifestations of metabolic syndrome].

Authors:  G Holzer; B Straßegger; B Volc-Platzer
Journal:  Hautarzt       Date:  2016-12       Impact factor: 0.751

4.  Serum lipid profile and clinical characteristics of patients with xanthelasma palpebrarum.

Authors:  Hossein Kavoussi; Ali Ebrahimi; Mansour Rezaei; Mazaher Ramezani; Behnaz Najafi; Reza Kavoussi
Journal:  An Bras Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.896

5.  Xanthelasma palpebrarum associated with increased cardio-ankle vascular index in asymptomatic subjects.

Authors:  Ali Rıza Akyüz; Turhan Turan; Musluhittin Emre Erkuş; İsmail Gürbak; Selim Kul; Levent Korkmaz; Mustafa Tarık Ağaç; Şükrü Çelik
Journal:  Wien Klin Wochenschr       Date:  2016-03-14       Impact factor: 1.704

6.  Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study.

Authors:  Mette Christoffersen; Ruth Frikke-Schmidt; Peter Schnohr; Gorm B Jensen; Børge G Nordestgaard; Anne Tybjærg-Hansen
Journal:  BMJ       Date:  2011-09-15

7.  Familial xanthelasma with dyslipidemia: just another family trait?

Authors:  Shridhar Dwivedi; Amitesh Aggarwal; Safal Singh; Vishal Sharma
Journal:  N Am J Med Sci       Date:  2012-05

8.  Correlating corneal arcus with atherosclerosis in familial hypercholesterolemia.

Authors:  Loren A Zech; Jeffery M Hoeg
Journal:  Lipids Health Dis       Date:  2008-03-10       Impact factor: 3.876

Review 9.  Xanthelasma palpebrarum - a brief review.

Authors:  Pragya A Nair; Rochit Singhal
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-12-18

10.  Xanthelasma Palpebrarum with Arcus Cornea: A Clinical and Biochemical Study.

Authors:  Pragya Ashok Nair; Chaitali R Patel; Jaishree D Ganjiwale; Nilofar Gulamsha Diwan; Nidhi Bhimjibhai Jivani
Journal:  Indian J Dermatol       Date:  2016 May-Jun       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.